dr. langer on afatinib for advanced non-small cell lung cancer
Published 9 years ago • 487 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:57
dr. langer on targeted therapies for locally advanced non-small cell lung cancer
-
1:07
dr. corey langer discusses erlotinib in advanced non-small cell lung cancer
-
0:45
dr. corey langer discusses afatinib in egfr-positive nsclc
-
2:03
dr. corey langer discusses treating locally advanced non-small cell lung cancer
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
0:58
the activity of afatinib in lung cancer
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
1:35
afatinib for advanced egfrm-positive nsclc
-
1:25
dr. chachoua on afatinib for exon 19 mutation in lung cancer
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
1:25
dr. bunn discusses afatinib in lung cancer
-
4:29
non–small cell lung cancer: other actionable mutations
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
4:06
afatinib in patients with uncommon egfr mutations
-
4:09
frontline afatinib in egfr-mutant nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
8:11
advances in frontline therapy for egfr nsclc
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations